Global Allergic Rhinitis Market Research Report – Pipeline Review, H2 2017

“The Latest Research Report Allergic Rhinitis-Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. –”

About Allergic Rhinitis Market

Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Allergic Rhinitis-Pipeline Review, H2 2017, provides an overview of the Allergic Rhinitis (Respiratory) pipeline landscape.

Allergic rhinitis is an allergic reaction that happens when immune system overreacts to substances that is inhaled. An allergen is something that triggers an allergy. When a person with allergic rhinitis breathes in an allergen such as pollen, mold, animal dander, or dust, the body releases chemicals that cause allergy symptoms. Symptoms of allergic rhinitis include stuffy runny nose, sneezing, swollen eyelids, itchy mouth, throat, ears.

Request For Sample Report @

Report Highlights

Global Markets Direct’s Pharmaceutical and Healthcare latest pipeline guide Allergic Rhinitis-Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Allergic Rhinitis (Respiratory), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Allergic Rhinitis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Allergic Rhinitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 6, 8, 16, 4, 14 and 2 respectively. Similarly, the Universities portfolio in Phase II and Preclinical stages comprises 2 and 3 molecules, respectively.

Allergic Rhinitis (Respiratory) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

View Sample PDF @


– The pipeline guide provides a snapshot of the global therapeutic landscape of Allergic Rhinitis (Respiratory).

– The pipeline guide reviews pipeline therapeutics for Allergic Rhinitis (Respiratory) by companies and universities/research institutes based on information derived from company and industry-specific sources.

– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

– The pipeline guide reviews key companies involved in Allergic Rhinitis (Respiratory) therapeutics and enlists all their major and minor projects.

– The pipeline guide evaluates Allergic Rhinitis (Respiratory) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

– The pipeline guide reviews latest news related to pipeline therapeutics for Allergic Rhinitis (Respiratory)

Reasons to buy

– Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

– Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

– Find and recognize significant and varied types of therapeutics under development for Allergic Rhinitis (Respiratory).

– Classify potential new clients or partners in the target demographic.

– Develop tactical initiatives by understanding the focus areas of leading companies.

– Plan mergers and acquisitions meritoriously by identifying key players and its most promising pipeline therapeutics.

– Formulate corrective measures for pipeline projects by understanding Allergic Rhinitis (Respiratory) pipeline depth and focus of Indication therapeutics.

– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

– Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Have Any Query? Ask Our Expert @

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Global Markets Direct Report Coverage 6

Allergic Rhinitis-Overview 7

Allergic Rhinitis-Therapeutics Development 8

Pipeline Overview 8

Pipeline by Companies 9

Pipeline by Universities/Institutes 12

Products under Development by Companies 13

Products under Development by Universities/Institutes 18

Allergic Rhinitis-Therapeutics Assessment 19

Assessment by Target 19

Assessment by Mechanism of Action 21

Assessment by Route of Administration 23

Assessment by Molecule Type 25

Allergic Rhinitis-Companies Involved in Therapeutics Development 27

Accolade Pharmaceuticals LLC 27


ALK-Abello A/S 27

AlleCures Inc 28

Allergy Therapeutics Plc 29

ASIT Biotech SA 29

Axikin Pharmaceuticals Inc 30

Chong Kun Dang Pharmaceutical Corp 30

Chrysalis BioTherapeutics Inc 30

Fountain Biopharma Inc 31

GlaxoSmithKline Plc 31

Glenmark Pharmaceuticals Ltd 32

HAL Allergy BV 32

Hisamitsu Pharmaceutical Co Inc 33

Intrommune Therapeutics 33

J Uriach Y Compania SA 34

Laboratorios LETI SL 34

Paradigm Biopharmaceuticals Ltd 34

Sanofi 35

Stallergenes Greer plc 35

Sun Pharma Advanced Research Company Ltd 36

Taiho Pharmaceutical Co Ltd 36

Therabron Therapeutics Inc 37

Xencor Inc 37

Allergic Rhinitis-Drug Profiles 39

(fexofenadine hydrochloride + phenylephrine hydrochloride)-Drug Profile 39

(mometasone furoate + olopatadine hydrochloride)-Drug Profile 40

854-A-Drug Profile 41

Allergen for Allergic Conjunctivitis and Allergic Rhinitis-Drug Profile 42

Allergen for Allergic Rhinitis-Drug Profile 43

Allergen for Allergic Rhinitis and Allergic Rhino-Conjunctivitis-Drug Profile 44

Allergen for Allergic Rhinitis and Rhinoconjunctivitis-Drug Profile 45

Allergen for Allergic Rhinitis, Allergic Rhino-Conjunctivitis and Allergic Asthma-Drug Profile 46

Allergen for Asthma and Perennial Allergic Rhinitis-Drug Profile 47

Allergen for Birch Pollen Induced Allergic Rhinitis and Rhinoconjunctivitis-Drug Profile 48

Allergen for House Dust Mite Induced Allergic Rhinitis and Rhinoconjunctivitis-Drug Profile 49

Allergen for House Dust Mites Induced Persistant Allergic Rhinitis and Rhinoconjunctivitis-Drug Profile 50

Allergen for Pollen Grass Allergy Induced Allergic Rhinitis and Rhinoconjunctivitis-Drug Profile 52

Allergen for Seasonal Grass Pollen Induced Allergic Rhinitis and Rhino-Conjunctivitis-Drug Profile 53

arabinogalactan-Drug Profile 54

B-244-Drug Profile 55

About us is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.


Mr. Nachiket

State Tower

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-621-2074



Designed by
Powered by
%d bloggers like this: